Well done Cyto, these type of opportunities do not come alone often to investors and I have decided to let all what I have ride, all though I am sure a lot less share wise than what you were dealing with. My break even SP price is somewhere around 40c area so my risk is quiet low in that regards. I am shooting for a $10 share price, may or may not happen this year but that's okay, as long as the Science continues to hold up it will get there. Mono HIV is pretty much a done deal, yes it could get extended if FDA delays approval for some stupid reason, that we should know by July I would think.